TAK-788 as First-line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations ~65 mi. (Santa Maria da Feira, Portugal, +144 more cities) Centro Hospitalar do Porto Hospital de Santo Antonio EGFR Exon 20 Insertion Non-Squamous Non-Small Cell Lung Carcinoma mobocertinib targeted therapy
Cancer Search
